AVEO Pharmaceuticals Announces Closing and Exercise of Over-Allotment Option

The total number of shares sold was 6352119, comprised of 5750000 shares of common stock initially offered and an additional 602119 shares of common stock sold pursuant to the underwriters' exercise of their over-allotment option.
See all stories on this topic »